BIO

Boston Convention & Exhibition Center 415 Summer St, Boston, MA, United States

BIO 2025 Join us at BIO 2025. The BIO International Convention is the largest and most comprehensive event for biotechnology, […]

ON Helix

The Cambridge Building The Cambridge Building, Babraham Research Campus, Cambridge, United Kingdom

ON Helix 2025 New Horizons for Bio Innovation Join us in Cambridge on 3 July 2025. One-day conference addresses key […]

AusBiotech

Melbourne Convention and Exhibition Centre 1 Convention Centre Pl, South Wharf, Melbourne, VIC, Australia

Join us at AusBiotech 2025.   For decades, the AusBiotech conference has served as the leading international meeting place for […]

AAPS PharmSci 360

Henry B. Gonzalez Convention Center 900 E Market St, San Antonio, TX, United States

Join us at AAPS PharmSci 360. PharmSci brings together leading researchers from academia and industry. You will hear about the […]

ACT Annual Meeting

JW Marriott Desert Ridge 5350 E Marriott Dr, Phoenix, AZ, United States

American College of Toxicology. 46th Annual Meeting (2025)   The Annual Meeting is the heart of ACT. Our November gathering […]

EBF

EBF Hyatt Regency Barcelona Tower, Gran Via 144, L’Hospitalet de Llobregat, Barcelona, Spain

European Bioanalysis Forum 18th EBF Open Symposium. Tuning into Tomorrow - Science in High Definition. Join us at EBF 2025.

Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

 

Patrick Bennett

Chief Executive Officer

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.